MedTrace Logo

Simvastatin in Uveitis

NCT04183387 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-12-03

No results posted yet for this study

Summary

The study evaluates anti-inflammatory effects and safety of simvastatin in non-infectious uveitis.

Conditions

  • Uveitis

Interventions

DRUG

Simvastatin 40mg

Sponsors & Collaborators

  • Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04183387 on ClinicalTrials.gov